A comprehensive view of Hospital / Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Regeneron Reports First Quarter 2024 Financial and Operating Results
Published:
May 03, 2024
by GlobeNewswire
|
Baxter reports first-quarter 2024 results
Published:
May 03, 2024
by Business Wire
|
Novartis to acquire preclinical-stage biotech Mariana Oncology, strengthening its radioligand therapy pipeline and research capabilities; Novartis to make upfront payment of US$1.0B, with additional US$750.0M upon reaching milestones
Published:
May 03, 2024
by PharmaBiz (India)
|
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Published:
May 02, 2024
by Benzinga Lightning Feed
|
Study finds Sanofi’s Beyfortus nirsevimab significantly reduced RSV lower respiratory tract disease and hospitalizations in infants in the 2023-2024 RSV season; the drug showed an 82% reduction in infant hospitalizations from RSV
Published:
May 02, 2024
by Sanofi SA
|
Ask us about our Bioeconomy market view